A ketone drink to alleviate the symptoms of PD 1.17

  • Research type

    Research Study

  • Full title

    Supplementation with a ketone ester drink to alleviate the symptoms of Parkinson’s disease

  • IRAS ID

    256914

  • Contact name

    Michele Hu

  • Contact email

    michele.hu@ndcn.ox.ac.uk

  • Sponsor organisation

    TdeltaS Ltd

  • ISRCTN Number

    ISRCTN64294760

  • Clinicaltrials.gov Identifier

    19/SC/0138, South Central - Berkshire

  • Duration of Study in the UK

    1 years, 10 months, 0 days

  • Research summary

    Parkinson’s disease (PD) is the second most common neurodegenerative disease worldwide. It is characterized by the death of dopamine-releasing neurons and manifests in a variety of progressive motor and nonmotor symptoms. While the exact causes of PD are not understood, it is believed that errors in energy metabolism contribute to the progression of the disease.

    Interventions that address these errors in energy metabolism may prevent the progression and improve the symptoms of PD. One promising intervention is the dietary administration of a ketone ester (ΔG®) that was developed by the Clarke group at the University of Oxford. ΔG® supplies the brain with ketone bodies, an alternative source of fuel to glucose. By improving energy metabolism in neurons, we hypothesize that ΔG® can ameliorate the symptoms of PD.

    This study will build on literature supporting the therapeutic efficacy of ketone bodies in neurodegeneration by investigating whether or not supplementation with ΔG® improves motor and nonmotor function in PD patients. PD patients will be randomized to receive either ΔG® or a placebo control drink for one month, during which time they will undergo a series of functional tests to monitor for changes in their symptoms. They will also provide blood samples to monitor for changes in metabolites relevant to their health. The results of this study may support the use of ΔG® as a safe non-pharmacological means of improving the symptoms of PD.

  • REC name

    South Central - Oxford B Research Ethics Committee

  • REC reference

    19/SC/0138

  • Date of REC Opinion

    10 May 2019

  • REC opinion

    Further Information Favourable Opinion